A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity

PHASE2CompletedINTERVENTIONAL
Enrollment

171

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

September 25, 2024

Study Completion Date

September 25, 2024

Conditions
Dentin Hypersensitivity
Interventions
DRUG

KH001

topical applications of KH001

DRUG

Placebo

topical applications of Water for Injection

Trial Locations (1)

Unknown

Kyung Hee University Dental Hospital, Seoul

All Listed Sponsors
lead

HysensBio Co., Ltd

INDUSTRY

NCT06264453 - A Study to Evaluate the Efficacy and Safety of KH001 in Patients with Dentin Hypersensitivity | Biotech Hunter | Biotech Hunter